Istituto di Chimica del Riconoscimento Molecolare , CNR Via Mario Bianco, 9 20131 Milano , Italy.
Department of Pharmaceutical Chemistry , University of California at San Francisco , San Francisco , California 94158 , United States.
ACS Chem Biol. 2018 Nov 16;13(11):3142-3152. doi: 10.1021/acschembio.8b00712. Epub 2018 Nov 8.
Allosteric inhibitors can be more difficult to optimize without an understanding of how their binding influences the conformational motions of the target. Here, we used an integrated computational and experimental approach to probe the molecular mechanism of an allosteric inhibitor of heat shock protein 70 (Hsp70). The anticancer compound, MKT-077, is known to bind a conserved site in members of the Hsp70 family, which favors the ADP-bound state and interferes with a protein-protein interaction (PPI) at long range. However, the binding site does not overlap with either the nucleotide-binding cleft or the PPI contact surface, so its mechanism is unclear. To this end, we modeled Hsp70's internal dynamics and studied how MKT-077 alters local sampling of its allosteric states. The results pointed to a set of concerted motions between five loops in Hsp70's nucleotide-binding domain (NBD), surrounding the MKT-077 binding site. To test this prediction, we mutated key residues and monitored chaperone activities in vitro. Together, the results indicate that MKT-077 interacts with loop222 to favor a pseudo-ADP bound conformer of Hsp70's NBD, even when ATP is present. We used this knowledge to synthesize an analog of MKT-077 that would better prevent motions of loop222 and confirmed that it had improved antiproliferative activity in breast cancer cells. These results provide an example of how to unlock and leverage the complex mechanisms of allosteric inhibitors.
变构抑制剂如果不了解其结合如何影响靶标的构象运动,就更难进行优化。在这里,我们使用集成的计算和实验方法来研究热休克蛋白 70(Hsp70)变构抑制剂的分子机制。抗癌化合物 MKT-077 已知与 Hsp70 家族成员中的保守位点结合,有利于 ADP 结合状态,并干扰长程的蛋白质-蛋白质相互作用(PPI)。然而,结合位点与核苷酸结合裂隙或 PPI 接触表面都不重叠,因此其机制尚不清楚。为此,我们对 Hsp70 的内部动力学进行了建模,并研究了 MKT-077 如何改变其变构状态的局部采样。结果指向 Hsp70 的核苷酸结合域(NBD)中五个环之间的一组协同运动,这些环围绕着 MKT-077 的结合位点。为了验证这一预测,我们突变了关键残基并在体外监测伴侣活性。总之,结果表明 MKT-077 与环 222 相互作用,有利于 Hsp70 的 NBD 呈现假 ADP 结合构象,即使存在 ATP 也是如此。我们利用这一知识合成了 MKT-077 的类似物,它可以更好地阻止环 222 的运动,并证实它在乳腺癌细胞中具有更好的抗增殖活性。这些结果提供了一个如何解锁和利用变构抑制剂复杂机制的范例。